Business Models in Neurotech Podcast Por  arte de portada

Business Models in Neurotech

Business Models in Neurotech

Escúchala gratis

Ver detalles del espectáculo
Welcome back to the Season 2 premiere of Neurotech Pub!In this episode, host and Paradromics CEO Matt Angle sits down with fellow Founder/CEOs Carolina Aguilar, Brian Pepin, and Kunal Ghosh to talk shop about building cutting edge neurotech companies from the ground up. We dive deep into business strategies, the neurotech fundraising landscape, emerging therapeutics, and more. We also provide an insider’s view of the intersections of data, pharma, and med devices that are shaping the future of healthcare. Pour yourself a cold one and settle in! Check out full video with transcript here: Check out video and a full episode transcript here. 00:00 | Updates & News >> INBRAIN Neuroelectronics raised a $17M Series A >> Rune Labs raised a $22.8 Million Series A >> Inscopix Launched Cloud-Based Platform for Data Management and Analysis2:15 | Meet the panel and pick up a book1:54 | Jester King Brewery 2:25 | Rune Labs 2:50 | Neurostimulator for deep brain stimulation therapy 3:23 | INBRAIN Neuroelectronics 4:11 | Inscopix 5:24 | Ursula K. Le Guin’s 'The Dispossessed' 6:19 | Yuval Noah Harari’s 'Sapiens: A Brief History of Humankind' 6:32 | Daniel G. Miller’s 'The Tree of Knowledge' 6:40 | Jiddu Krishnamurti’s 'The Book of Life' 7:34 | Barack Obama’s 'A Promised Land,' ‘Dreams from my Father,’ & ‘The Audacity of Hope’ 7:56 | Karl Popper’s 'The Open Society and Its Enemies'9:25 | Venture Capital in Neurotech34:44 | Business Strategy in Neurotech40:32 | Tom Oxley, CEO, Synchron 43:58 | Dr. Thomas Insel 44:06 | Mindstrong Mental Health Care 44:35 | Aduhelm controversy 52:25 | Galvani Bio 59:39 | Percept Neurostimulator 1:00:32 | Neuromodulation and the future of treating brain disease 1:07:21 | Software as a Medical Device FDA Guidance1:09:12 | State of Animal Model Systems1:14:28 | α-Synuclein in Parkinson's Disease 1:18:01 | Alto Neuroscience 1:18:36 | Flatiron Foundation 1:18:45 | Gaurdent Health 1:19:03 | Melanoma Trends & Rates1:21:41 | The Pharma-Data-Device Ecosystem 1:21:42 | Frank Fischer, Chairman of Neuropace 1:22:28 | Neurotech Pub Season 1, Episode 9 1:26:35 | Roche acquisition of Flatiron Health & merger with Foundation Medicine 1:27:12 | Companion Diagnostics 1:28:29 | Adhulem and PET imaging 1:29:09 | Resignations at the FDA over Alzheimer’s Drug 1:29:32 | Derek Lowe’s take on the Aducanumab Approval, FDA Committee Votes, Halting the Aducanumab Trials, & The FDA Advisory Committee Briefing Document on Aducanumab 1:31:39 | Donanemab receives breakthrough therapy designation in 2021 1:36:58 | Mapping the Frontal-Vagal Pathway 1:37:09 | The Human Connectome Project 1:40:07 | Teal Organizations and Holacracy 1:41:18 | Society for Neuroscience 1:44:37 | Affymetrix (Thermo Fisher Scientific) 1:44:39 | IlluminaWant more?Follow Paradromics & Neurotech Pub on Twitter Follow Matt, Brian, Carolina, & Kunal on Twitter
Todavía no hay opiniones